The content discusses the cost-effectiveness of mailing self-sampling kits for high-risk human papillomavirus (HPV) to increase cervical cancer screening uptake. The study analyzed almost 20,000 women in a randomized trial, highlighting the effectiveness of this strategy, especially in women aged 50-64 years and those recently overdue for screening. The authors emphasize the importance of this outreach strategy in US healthcare systems, particularly in overcoming screening barriers among underscreened women. The study's economic evaluation and results on screening uptake, positive test results, and treatment rates provide valuable insights into the benefits of home-based HPV screening.
他の言語に翻訳
原文コンテンツから
www.medscape.com
抽出されたキーインサイト
by Liam Davenpo... 場所 www.medscape.com 03-22-2023
https://www.medscape.com/viewarticle/989961深掘り質問